BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26049706)

  • 21. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Campos C; Perrey A; Lambert C; Pereira B; Goutte M; Dubois A; Goutorbe F; Dapoigny M; Bommelaer G; Hordonneau C; Buisson A
    Dig Dis Sci; 2017 Jun; 62(6):1628-1636. PubMed ID: 28401425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study.
    Bouhnik Y; Carbonnel F; Laharie D; Stefanescu C; Hébuterne X; Abitbol V; Nachury M; Brixi H; Bourreille A; Picon L; Bourrier A; Allez M; Peyrin-Biroulet L; Moreau J; Savoye G; Fumery M; Nancey S; Roblin X; Altwegg R; Bouguen G; Bommelaer G; Danese S; Louis E; Zappa M; Mary JY;
    Gut; 2018 Jan; 67(1):53-60. PubMed ID: 28119352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of magnetic resonance enterography in the management of Crohn disease.
    Messaris E; Chandolias N; Grand D; Pricolo V
    Arch Surg; 2010 May; 145(5):471-5. PubMed ID: 20479346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of tumour necrosis factor antagonists in stricturing Crohn's disease: A tertiary center real-life experience.
    Allocca M; Bonifacio C; Fiorino G; Spinelli A; Furfaro F; Balzarini L; Bonovas S; Danese S
    Dig Liver Dis; 2017 Aug; 49(8):872-877. PubMed ID: 28416240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of adalimumab for the management of inflammatory bowel disease in the clinical setting.
    Trinder MW; Lawrance IC
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1252-7. PubMed ID: 19220669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of Durability of Radiological Response in Patients With Small Bowel Crohn's Disease.
    Deepak P; Fletcher JG; Fidler JL; Barlow JM; Sheedy SP; Kolbe AB; Harmsen WS; Therneau T; Hansel SL; Becker BD; Loftus EV; Bruining DH
    Inflamm Bowel Dis; 2018 Jul; 24(8):1815-1825. PubMed ID: 29668921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interobserver and intermodality agreement for detection of small bowel Crohn's disease with MR enterography and CT enterography.
    Jensen MD; Ormstrup T; Vagn-Hansen C; Østergaard L; Rafaelsen SR
    Inflamm Bowel Dis; 2011 May; 17(5):1081-8. PubMed ID: 21484959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accuracy of CT enterography and magnetic resonance enterography imaging to detect lesions preoperatively in patients undergoing surgery for Crohn's disease.
    Seastedt KP; Trencheva K; Michelassi F; Alsaleh D; Milsom JW; Sonoda T; Lee SW; Nandakumar G
    Dis Colon Rectum; 2014 Dec; 57(12):1364-70. PubMed ID: 25380001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for surgery in stricturing small bowel Crohn's disease: A retrospective cohort study from the GETAID pédiatrique.
    Lacotte E; Boujonnier L; Martinez-Vinson C; Viala J; Ley D; Coopman S; Lerisson H; Dabadie A; Dumant-Forrest C; Pigneur B; Ruemmele F; Enaud R; Comte A; Rebeuh J; Bertrand V; Caron N; Breton A; Duclaux-Loras R; Vasies I; Dupont-Lucas C
    J Pediatr Gastroenterol Nutr; 2024 Jun; 78(6):1261-1272. PubMed ID: 38651614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of Magnetic Resonance Enterography For Small Bowel Endoscopic Healing in Patients With Crohn's Disease.
    Takenaka K; Ohtsuka K; Kitazume Y; Matsuoka K; Nagahori M; Fujii T; Saito E; Kimura M; Fujioka T; Watanabe M
    Am J Gastroenterol; 2018 Feb; 113(2):283-294. PubMed ID: 29257147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small bowel stricture is associated with abnormal motility on the cine MRI sequence in patients with Crohn's disease.
    Lambrou T; Chaudhry NA; Grajo JR; Moser P; Riverso M; Mramba LK; Zimmermann EM
    Eur J Radiol; 2019 Sep; 118():264-270. PubMed ID: 31439253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracies of MR enterography and CT enterography in symptomatic Crohn's disease.
    Jensen MD; Kjeldsen J; Rafaelsen SR; Nathan T
    Scand J Gastroenterol; 2011 Dec; 46(12):1449-57. PubMed ID: 21905974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying Patients at High Risk of Loss of Response to Infliximab Maintenance Therapy in Paediatric Crohn's Disease.
    Dupont-Lucas C; Sternszus R; Ezri J; Leibovitch S; Gervais F; Amre D; Deslandres C
    J Crohns Colitis; 2016 Jul; 10(7):795-804. PubMed ID: 26822611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosal expression of basic fibroblastic growth factor, syndecan 1 and tumour necrosis factor-α in Crohn's disease in deep remission under treatment with anti-TNFα antibodies.
    Tursi A; Elisei W; Principi M; Inchingolo CD; Nenna R; Picchio M; Giorgio F; Ierardi E; Brandimarte G
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):261-5. PubMed ID: 25267953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small bowel strictures in Crohn's disease: a quantitative investigation of intestinal motility using MR enterography.
    Menys A; Helbren E; Makanyanga J; Emmanuel A; Forbes A; Windsor A; Punwani S; Halligan S; Atkinson D; Taylor SA
    Neurogastroenterol Motil; 2013 Dec; 25(12):967-e775. PubMed ID: 24028647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn's disease?
    Bhalme M; Sharma A; Keld R; Willert R; Campbell S
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):543-9. PubMed ID: 23337170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diffusion-weighted magnetic resonance enterocolonography in predicting remission after anti-TNF induction therapy in Crohn's disease.
    Buisson A; Hordonneau C; Goutte M; Scanzi J; Goutorbe F; Klotz T; Boyer L; Pereira B; Bommelaer G
    Dig Liver Dis; 2016 Mar; 48(3):260-6. PubMed ID: 26699828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study.
    Feagan BG; Panaccione R; Sandborn WJ; D'Haens GR; Schreiber S; Rutgeerts PJ; Loftus EV; Lomax KG; Yu AP; Wu EQ; Chao J; Mulani P
    Gastroenterology; 2008 Nov; 135(5):1493-9. PubMed ID: 18848553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of anti-TNFα drugs in patients with Crohn's disease who do not achieve remission with their first anti-TNFα agent.
    R-Grau Mdel C; Chaparro M; Mesonero F; Barreiro-de Acosta M; Castro L; Castro M; Domènech E; Mancenido N; Pérez-Calle JL; Taxonera C; Barrio J; De Francisco R; Fernández-Salgado E; Luzón L; Merino O; Oltra L; Saro C; Bermejo F; García-Sánchez V; Ginard D; Gutiérrez A; Vera I; Antón R; Ber Y; Calvet X; Gisbert JP
    Dig Liver Dis; 2016 Jun; 48(6):613-9. PubMed ID: 26992847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
    Sands BE; Feagan BG; Rutgeerts P; Colombel JF; Sandborn WJ; Sy R; D'Haens G; Ben-Horin S; Xu J; Rosario M; Fox I; Parikh A; Milch C; Hanauer S
    Gastroenterology; 2014 Sep; 147(3):618-627.e3. PubMed ID: 24859203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.